The price of teriparatide injections can vary based on factors such as dosage, quantity, and location. For example, a 2.4 mL vial of 20 mcg/0.08 mL teriparatide injection, often used for osteoporosis treatment, has been reported to cost around $750 to $800 in some markets [1]. These injections are typically administered by healthcare professionals.
How is teriparatide prescribed?
Teriparatide is an injectable medication approved for the treatment of osteoporosis in postmenopausal women and men at high risk for fracture, as well as for men and women with glucocorticoid-induced osteoporosis. It is also used to treat osteoporosis in individuals with multiple fractures or vertebral fractures [2]. It is a recombinant form of parathyroid hormone (PTH) [2].
How long does teriparatide treatment typically last?
Treatment with teriparatide is generally limited to a maximum of 2 years. The drug is intended for short-term use, and its safety and efficacy beyond 2 years have not been established. After completing teriparatide treatment, patients are typically transitioned to other osteoporosis therapies to maintain bone density gains [2].
What are the potential side effects of teriparatide?
Common side effects of teriparatide injections include nausea, joint pain, leg cramps, and headache. Less common but serious side effects may include dizziness, increased calcium levels, and a rare risk of osteosarcoma observed in animal studies. Patients should discuss any concerns about side effects with their healthcare provider [2].
When does patent exclusivity expire for teriparatide?
Patent information for pharmaceutical products is complex and can involve multiple patents covering different aspects of the drug, such as the active ingredient, formulation, or method of use. DrugPatentWatch.com is a resource that tracks patent and exclusivity data for pharmaceuticals [3]. For specific patent expiry dates related to teriparatide, consulting such databases is recommended.
Are there other options for osteoporosis treatment?
Besides teriparatide, other medications are available for managing osteoporosis. These include bisphosphonates, denosumab, raloxifene, and calcium and vitamin D supplements. The choice of treatment depends on individual patient factors, including fracture risk, medical history, and preference [4].